Global Type 2 Diabetes Medication Market Growth (Status and Outlook) 2020-2025
Apr, 2020
|
Report ID: 123311
|
139
|
Pharmaceuticals and Healthcare
According to this study, over the next five years the Type 2 Diabetes Medication market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Type 2 Diabetes Medication business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Type 2 Diabetes Medication market by type, application, key companies and key regions.
This study considers the Type 2 Diabetes Medication value generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Biguanides
Sulphonylureas
Thiazolidinediones
Alpha-glucosidase Inhibitors
DPP-4 Inhibitors
GLP-1 Receptor Agonists
SGLT-2 Inhibitors
Insulins
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
AstraZeneca
Pfizer
Novartis
Johnson & Johnson
Boehringer Ingelheim
Novo Nordisk
Merck
Bristol-Myers Squibb
Sanofi
Eli Lilly
Takeda
Sun pharma
Astellas Pharma
Glenmark
Biocon
Bayer AG
Daiichi Sankyo
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Type 2 Diabetes Medication market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Type 2 Diabetes Medication market by identifying its various subsegments.
Focuses on the key global Type 2 Diabetes Medication players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Type 2 Diabetes Medication with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Type 2 Diabetes Medication submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
This report presents a comprehensive overview, market shares and growth opportunities of Type 2 Diabetes Medication market by type, application, key companies and key regions.
This study considers the Type 2 Diabetes Medication value generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Biguanides
Sulphonylureas
Thiazolidinediones
Alpha-glucosidase Inhibitors
DPP-4 Inhibitors
GLP-1 Receptor Agonists
SGLT-2 Inhibitors
Insulins
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
AstraZeneca
Pfizer
Novartis
Johnson & Johnson
Boehringer Ingelheim
Novo Nordisk
Merck
Bristol-Myers Squibb
Sanofi
Eli Lilly
Takeda
Sun pharma
Astellas Pharma
Glenmark
Biocon
Bayer AG
Daiichi Sankyo
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Type 2 Diabetes Medication market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Type 2 Diabetes Medication market by identifying its various subsegments.
Focuses on the key global Type 2 Diabetes Medication players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Type 2 Diabetes Medication with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Type 2 Diabetes Medication submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Type 2 Diabetes Medication Market Size 2015-2025
2.1.2 Type 2 Diabetes Medication Market Size CAGR by Region
2.2 Type 2 Diabetes Medication Segment by Type
2.2.1 Biguanides
2.2.2 Biguanides
2.2.3 Thiazolidinediones
2.2.4 Alpha-glucosidase Inhibitors
2.2.5 DPP-4 Inhibitors
2.2.6 GLP-1 Receptor Agonists
2.2.7 SGLT-2 Inhibitors
2.2.8 Insulins
2.3 Type 2 Diabetes Medication Market Size by Type
2.3.1 Global Type 2 Diabetes Medication Market Size Market Share by Type (2015-2020)
2.3.2 Global Type 2 Diabetes Medication Market Size Growth Rate by Type (2015-2020)
2.4 Type 2 Diabetes Medication Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Type 2 Diabetes Medication Market Size by Application
2.5.1 Global Type 2 Diabetes Medication Market Size Market Share by Application (2015-2020)
2.5.2 Global Type 2 Diabetes Medication Market Size Growth Rate by Application (2015-2020)
3 Global Type 2 Diabetes Medication by Players
3.1 Global Type 2 Diabetes Medication Market Size Market Share by Players
3.1.1 Global Type 2 Diabetes Medication Market Size by Players (2018-2020)
3.1.2 Global Type 2 Diabetes Medication Market Size Market Share by Players (2018-2020)
3.2 Global Type 2 Diabetes Medication Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Type 2 Diabetes Medication by Regions
4.1 Type 2 Diabetes Medication Market Size by Regions
4.2 Americas Type 2 Diabetes Medication Market Size Growth
4.3 APAC Type 2 Diabetes Medication Market Size Growth
4.4 Europe Type 2 Diabetes Medication Market Size Growth
4.5 Middle East & Africa Type 2 Diabetes Medication Market Size Growth
5 Americas
5.1 Americas Type 2 Diabetes Medication Market Size by Countries
5.2 Americas Type 2 Diabetes Medication Market Size by Type
5.3 Americas Type 2 Diabetes Medication Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Type 2 Diabetes Medication Market Size by Regions
6.2 APAC Type 2 Diabetes Medication Market Size by Type
6.3 APAC Type 2 Diabetes Medication Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Type 2 Diabetes Medication by Countries
7.2 Europe Type 2 Diabetes Medication Market Size by Type
7.3 Europe Type 2 Diabetes Medication Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Type 2 Diabetes Medication by Countries
8.2 Middle East & Africa Type 2 Diabetes Medication Market Size by Type
8.3 Middle East & Africa Type 2 Diabetes Medication Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Type 2 Diabetes Medication Market Forecast
10.1 Global Type 2 Diabetes Medication Market Size Forecast (2021-2025)
10.2 Global Type 2 Diabetes Medication Forecast by Regions
10.2.1 Global Type 2 Diabetes Medication Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Type 2 Diabetes Medication Forecast by Type
10.8 Global Type 2 Diabetes Medication Forecast by Application
11 Key Players Analysis
11.1 AstraZeneca
11.1.1 Company Details
11.1.2 Type 2 Diabetes Medication Product Offered
11.1.3 AstraZeneca Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 AstraZeneca News
11.2 Pfizer
11.2.1 Company Details
11.2.2 Type 2 Diabetes Medication Product Offered
11.2.3 Pfizer Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Pfizer News
11.3 Novartis
11.3.1 Company Details
11.3.2 Type 2 Diabetes Medication Product Offered
11.3.3 Novartis Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Novartis News
11.4 Johnson & Johnson
11.4.1 Company Details
11.4.2 Type 2 Diabetes Medication Product Offered
11.4.3 Johnson & Johnson Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Johnson & Johnson News
11.5 Boehringer Ingelheim
11.5.1 Company Details
11.5.2 Type 2 Diabetes Medication Product Offered
11.5.3 Boehringer Ingelheim Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Boehringer Ingelheim News
11.6 Novo Nordisk
11.6.1 Company Details
11.6.2 Type 2 Diabetes Medication Product Offered
11.6.3 Novo Nordisk Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Novo Nordisk News
11.7 Merck
11.7.1 Company Details
11.7.2 Type 2 Diabetes Medication Product Offered
11.7.3 Merck Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Merck News
11.8 Bristol-Myers Squibb
11.8.1 Company Details
11.8.2 Type 2 Diabetes Medication Product Offered
11.8.3 Bristol-Myers Squibb Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Bristol-Myers Squibb News
11.9 Sanofi
11.9.1 Company Details
11.9.2 Type 2 Diabetes Medication Product Offered
11.9.3 Sanofi Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 Sanofi News
11.10 Eli Lilly
11.10.1 Company Details
11.10.2 Type 2 Diabetes Medication Product Offered
11.10.3 Eli Lilly Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 Eli Lilly News
11.11 Takeda
11.12 Sun pharma
11.13 Astellas Pharma
11.14 Glenmark
11.15 Biocon
11.16 Bayer AG
11.17 Daiichi Sankyo
12 Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Type 2 Diabetes Medication Market Size 2015-2025
2.1.2 Type 2 Diabetes Medication Market Size CAGR by Region
2.2 Type 2 Diabetes Medication Segment by Type
2.2.1 Biguanides
2.2.2 Biguanides
2.2.3 Thiazolidinediones
2.2.4 Alpha-glucosidase Inhibitors
2.2.5 DPP-4 Inhibitors
2.2.6 GLP-1 Receptor Agonists
2.2.7 SGLT-2 Inhibitors
2.2.8 Insulins
2.3 Type 2 Diabetes Medication Market Size by Type
2.3.1 Global Type 2 Diabetes Medication Market Size Market Share by Type (2015-2020)
2.3.2 Global Type 2 Diabetes Medication Market Size Growth Rate by Type (2015-2020)
2.4 Type 2 Diabetes Medication Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Type 2 Diabetes Medication Market Size by Application
2.5.1 Global Type 2 Diabetes Medication Market Size Market Share by Application (2015-2020)
2.5.2 Global Type 2 Diabetes Medication Market Size Growth Rate by Application (2015-2020)
3 Global Type 2 Diabetes Medication by Players
3.1 Global Type 2 Diabetes Medication Market Size Market Share by Players
3.1.1 Global Type 2 Diabetes Medication Market Size by Players (2018-2020)
3.1.2 Global Type 2 Diabetes Medication Market Size Market Share by Players (2018-2020)
3.2 Global Type 2 Diabetes Medication Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Type 2 Diabetes Medication by Regions
4.1 Type 2 Diabetes Medication Market Size by Regions
4.2 Americas Type 2 Diabetes Medication Market Size Growth
4.3 APAC Type 2 Diabetes Medication Market Size Growth
4.4 Europe Type 2 Diabetes Medication Market Size Growth
4.5 Middle East & Africa Type 2 Diabetes Medication Market Size Growth
5 Americas
5.1 Americas Type 2 Diabetes Medication Market Size by Countries
5.2 Americas Type 2 Diabetes Medication Market Size by Type
5.3 Americas Type 2 Diabetes Medication Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Type 2 Diabetes Medication Market Size by Regions
6.2 APAC Type 2 Diabetes Medication Market Size by Type
6.3 APAC Type 2 Diabetes Medication Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Type 2 Diabetes Medication by Countries
7.2 Europe Type 2 Diabetes Medication Market Size by Type
7.3 Europe Type 2 Diabetes Medication Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Type 2 Diabetes Medication by Countries
8.2 Middle East & Africa Type 2 Diabetes Medication Market Size by Type
8.3 Middle East & Africa Type 2 Diabetes Medication Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Type 2 Diabetes Medication Market Forecast
10.1 Global Type 2 Diabetes Medication Market Size Forecast (2021-2025)
10.2 Global Type 2 Diabetes Medication Forecast by Regions
10.2.1 Global Type 2 Diabetes Medication Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Type 2 Diabetes Medication Forecast by Type
10.8 Global Type 2 Diabetes Medication Forecast by Application
11 Key Players Analysis
11.1 AstraZeneca
11.1.1 Company Details
11.1.2 Type 2 Diabetes Medication Product Offered
11.1.3 AstraZeneca Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 AstraZeneca News
11.2 Pfizer
11.2.1 Company Details
11.2.2 Type 2 Diabetes Medication Product Offered
11.2.3 Pfizer Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Pfizer News
11.3 Novartis
11.3.1 Company Details
11.3.2 Type 2 Diabetes Medication Product Offered
11.3.3 Novartis Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Novartis News
11.4 Johnson & Johnson
11.4.1 Company Details
11.4.2 Type 2 Diabetes Medication Product Offered
11.4.3 Johnson & Johnson Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Johnson & Johnson News
11.5 Boehringer Ingelheim
11.5.1 Company Details
11.5.2 Type 2 Diabetes Medication Product Offered
11.5.3 Boehringer Ingelheim Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Boehringer Ingelheim News
11.6 Novo Nordisk
11.6.1 Company Details
11.6.2 Type 2 Diabetes Medication Product Offered
11.6.3 Novo Nordisk Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Novo Nordisk News
11.7 Merck
11.7.1 Company Details
11.7.2 Type 2 Diabetes Medication Product Offered
11.7.3 Merck Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Merck News
11.8 Bristol-Myers Squibb
11.8.1 Company Details
11.8.2 Type 2 Diabetes Medication Product Offered
11.8.3 Bristol-Myers Squibb Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Bristol-Myers Squibb News
11.9 Sanofi
11.9.1 Company Details
11.9.2 Type 2 Diabetes Medication Product Offered
11.9.3 Sanofi Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 Sanofi News
11.10 Eli Lilly
11.10.1 Company Details
11.10.2 Type 2 Diabetes Medication Product Offered
11.10.3 Eli Lilly Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 Eli Lilly News
11.11 Takeda
11.12 Sun pharma
11.13 Astellas Pharma
11.14 Glenmark
11.15 Biocon
11.16 Bayer AG
11.17 Daiichi Sankyo
12 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Type 2 Diabetes Medication Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Biguanides
Table 5. Major Players of Sulphonylureas
Table 6. Major Players of Thiazolidinediones
Table 7. Major Players of Alpha-glucosidase Inhibitors
Table 8. Major Players of DPP-4 Inhibitors
Table 9. Major Players of GLP-1 Receptor Agonists
Table 10. Major Players of SGLT-2 Inhibitors
Table 11. Major Players of Insulins
Table 12. Type 2 Diabetes Medication Market Size by Type (2014-2019) ($ Millions)
Table 13. Global Type 2 Diabetes Medication Market Size Market Share by Type (2015-2020)
Table 14. Global Type 2 Diabetes Medication Market Size by Application (2015-2020) ($ Millions)
Table 15. Global Type 2 Diabetes Medication Market Size Market Share by Application (2015-2020)
Table 16. Global Type 2 Diabetes Medication Revenue by Players (2018-2020) ($ Millions)
Table 17. Global Type 2 Diabetes Medication Revenue Market Share by Players (2018-2020)
Table 18. Global Type 2 Diabetes Medication Key Players Head office and Products Offered
Table 19. Type 2 Diabetes Medication Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global Type 2 Diabetes Medication Market Size by Regions 2015-2020 ($ Millions)
Table 23. Global Type 2 Diabetes Medication Market Size Market Share by Regions 2015-2020
Table 24. Americas Type 2 Diabetes Medication Market Size by Countries (2015-2020) ($ Millions)
Table 25. Americas Type 2 Diabetes Medication Market Size Market Share by Countries (2015-2020)
Table 26. Americas Type 2 Diabetes Medication Market Size by Type (2015-2020) ($ Millions)
Table 27. Americas Type 2 Diabetes Medication Market Size Market Share by Type (2015-2020)
Table 28. Americas Type 2 Diabetes Medication Market Size by Application (2015-2020) ($ Millions)
Table 29. Americas Type 2 Diabetes Medication Market Size Market Share by Application (2015-2020)
Table 30. APAC Type 2 Diabetes Medication Market Size by Regions (2015-2020) ($ Millions)
Table 31. APAC Type 2 Diabetes Medication Market Size Market Share by Regions (2015-2020)
Table 32. APAC Type 2 Diabetes Medication Market Size by Type (2015-2020) ($ Millions)
Table 33. APAC Type 2 Diabetes Medication Market Size Market Share by Type (2015-2020)
Table 34. APAC Type 2 Diabetes Medication Market Size by Application (2015-2020) ($ Millions)
Table 35. APAC Type 2 Diabetes Medication Market Size Market Share by Application (2015-2020)
Table 36. Europe Type 2 Diabetes Medication Market Size by Countries (2015-2020) ($ Millions)
Table 37. Europe Type 2 Diabetes Medication Market Size Market Share by Countries (2015-2020)
Table 38. Europe Type 2 Diabetes Medication Market Size by Type (2015-2020) ($ Millions)
Table 39. Europe Type 2 Diabetes Medication Market Size Market Share by Type (2015-2020)
Table 40. Europe Type 2 Diabetes Medication Market Size by Application (2015-2020) ($ Millions)
Table 41. Europe Type 2 Diabetes Medication Market Size Market Share by Application (2015-2020)
Table 42. Middle East & Africa Type 2 Diabetes Medication Market Size by Countries (2015-2020) ($ Millions)
Table 43. Middle East & Africa Type 2 Diabetes Medication Market Size Market Share by Countries (2015-2020)
Table 44. Middle East & Africa Type 2 Diabetes Medication Market Size by Type (2015-2020) ($ Millions)
Table 45. Middle East & Africa Type 2 Diabetes Medication Market Size Market Share by Type (2015-2020)
Table 46. Middle East & Africa Type 2 Diabetes Medication Market Size by Application (2015-2020) ($ Millions)
Table 47. Middle East & Africa Type 2 Diabetes Medication Market Size Market Share by Application (2015-2020)
Table 48. Key and Potential Regions of Type 2 Diabetes Medication
Table 49. Key Application and Potential Industries of Type 2 Diabetes Medication
Table 50. Key Challenges of Type 2 Diabetes Medication
Table 51. Key Trends of Type 2 Diabetes Medication
Table 52. Global Type 2 Diabetes Medication Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 53. Global Type 2 Diabetes Medication Market Size Market Share Forecast by Regions
Table 54. Global Type 2 Diabetes Medication Market Size Forecast by Type (2021-2025) ($ Millions)
Table 55. Global Type 2 Diabetes Medication Market Size Market Share Forecast by Type (2021-2025)
Table 56. Global Type 2 Diabetes Medication Market Size Forecast by Application (2021-2025) ($ Millions)
Table 57. Global Type 2 Diabetes Medication Market Size Market Share Forecast by Application (2021-2025)
Table 58. AstraZeneca Details, Company Total Revenue (in $ million), Head Office, Type 2 Diabetes Medication Major Market Areas and Its Competitors
Table 59. AstraZeneca Type 2 Diabetes Medication Product Offered
Table 60. AstraZeneca Type 2 Diabetes Medication Revenue and Gross Margin (2018-2020E)
Table 61. AstraZeneca Main Business
Table 62. AstraZeneca Latest Developments
Table 63. Pfizer Details, Company Total Revenue (in $ million), Head Office, Type 2 Diabetes Medication Major Market Areas and Its Competitors
Table 64. Pfizer Type 2 Diabetes Medication Product Offered
Table 65. Pfizer Main Business
Table 66. Pfizer Type 2 Diabetes Medication Revenue and Gross Margin (2018-2020E)
Table 67. Pfizer Latest Developments
Table 68. Novartis Details, Company Total Revenue (in $ million), Head Office, Type 2 Diabetes Medication Major Market Areas and Its Competitors
Table 69. Novartis Type 2 Diabetes Medication Product Offered
Table 70. Novartis Main Business
Table 71. Novartis Type 2 Diabetes Medication Revenue and Gross Margin (2018-2020E)
Table 72. Novartis Latest Developments
Table 73. Johnson & Johnson Details, Company Total Revenue (in $ million), Head Office, Type 2 Diabetes Medication Major Market Areas and Its Competitors
Table 74. Johnson & Johnson Type 2 Diabetes Medication Product Offered
Table 75. Johnson & Johnson Main Business
Table 76. Johnson & Johnson Type 2 Diabetes Medication Revenue and Gross Margin (2018-2020E)
Table 77. Johnson & Johnson Latest Developments
Table 78. Boehringer Ingelheim Details, Company Total Revenue (in $ million), Head Office, Type 2 Diabetes Medication Major Market Areas and Its Competitors
Table 79. Boehringer Ingelheim Type 2 Diabetes Medication Product Offered
Table 80. Boehringer Ingelheim Main Business
Table 81. Boehringer Ingelheim Type 2 Diabetes Medication Revenue and Gross Margin (2018-2020E)
Table 82. Boehringer Ingelheim Latest Developments
Table 83. Novo Nordisk Details, Company Total Revenue (in $ million), Head Office, Type 2 Diabetes Medication Major Market Areas and Its Competitors
Table 84. Novo Nordisk Type 2 Diabetes Medication Product Offered
Table 85. Novo Nordisk Main Business
Table 86. Novo Nordisk Type 2 Diabetes Medication Revenue and Gross Margin (2018-2020E)
Table 87. Novo Nordisk Latest Developments
Table 88. Merck Details, Company Total Revenue (in $ million), Head Office, Type 2 Diabetes Medication Major Market Areas and Its Competitors
Table 89. Merck Type 2 Diabetes Medication Product Offered
Table 90. Merck Main Business
Table 91. Merck Type 2 Diabetes Medication Revenue and Gross Margin (2018-2020E)
Table 92. Merck Latest Developments
Table 93. Bristol-Myers Squibb Details, Company Total Revenue (in $ million), Head Office, Type 2 Diabetes Medication Major Market Areas and Its Competitors
Table 94. Bristol-Myers Squibb Type 2 Diabetes Medication Product Offered
Table 95. Bristol-Myers Squibb Main Business
Table 96. Bristol-Myers Squibb Type 2 Diabetes Medication Revenue and Gross Margin (2018-2020E)
Table 97. Bristol-Myers Squibb Latest Developments
Table 98. Sanofi Details, Company Total Revenue (in $ million), Head Office, Type 2 Diabetes Medication Major Market Areas and Its Competitors
Table 99. Sanofi Type 2 Diabetes Medication Product Offered
Table 100. Sanofi Main Business
Table 101. Sanofi Type 2 Diabetes Medication Revenue and Gross Margin (2018-2020E)
Table 102. Sanofi Latest Developments
Table 103. Eli Lilly Details, Company Total Revenue (in $ million), Head Office, Type 2 Diabetes Medication Major Market Areas and Its Competitors
Table 104. Eli Lilly Type 2 Diabetes Medication Product Offered
Table 105. Eli Lilly Main Business
Table 106. Eli Lilly Type 2 Diabetes Medication Revenue and Gross Margin (2018-2020E)
Table 107. Eli Lilly Latest Developments
Table 108. Takeda Details, Company Total Revenue (in $ million), Head Office, Type 2 Diabetes Medication Major Market Areas and Its Competitors
Table 109. Sun pharma Details, Company Total Revenue (in $ million), Head Office, Type 2 Diabetes Medication Major Market Areas and Its Competitors
Table 110. Astellas Pharma Details, Company Total Revenue (in $ million), Head Office, Type 2 Diabetes Medication Major Market Areas and Its Competitors
Table 111. Glenmark Details, Company Total Revenue (in $ million), Head Office, Type 2 Diabetes Medication Major Market Areas and Its Competitors
Table 112. Biocon Details, Company Total Revenue (in $ million), Head Office, Type 2 Diabetes Medication Major Market Areas and Its Competitors
Table 113. Bayer AG Details, Company Total Revenue (in $ million), Head Office, Type 2 Diabetes Medication Major Market Areas and Its Competitors
Table 114. Daiichi Sankyo Details, Company Total Revenue (in $ million), Head Office, Type 2 Diabetes Medication Major Market Areas and Its Competitors
List of Figures
Figure 1. Type 2 Diabetes Medication Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Type 2 Diabetes Medication Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Type 2 Diabetes Medication Market Size Market Share by Type (2015-2020)
Figure 5. Global Biguanides Market Size Growth Rate
Figure 6. Global Sulphonylureas Market Size Growth Rate
Figure 7. Global Thiazolidinediones Market Size Growth Rate
Figure 8. Global Alpha-glucosidase Inhibitors Market Size Growth Rate
Figure 9. Global DPP-4 Inhibitors Market Size Growth Rate
Figure 10. Global GLP-1 Receptor Agonists Market Size Growth Rate
Figure 11. Global SGLT-2 Inhibitors Market Size Growth Rate
Figure 12. Global Insulins Market Size Growth Rate
Figure 13. Type 2 Diabetes Medication in Hospital Pharmacies
Figure 14. Global Type 2 Diabetes Medication Market: Hospital Pharmacies (2015-2020) ($ Millions)
Figure 15. Type 2 Diabetes Medication in Retail Pharmacies
Figure 16. Global Type 2 Diabetes Medication Market: Retail Pharmacies (2015-2020) ($ Millions)
Figure 17. Type 2 Diabetes Medication in Online Pharmacies
Figure 18. Global Type 2 Diabetes Medication Market: Online Pharmacies (2015-2020) ($ Millions)
Figure 19. Global Online Pharmacies YoY Growth ($ Millions)
Figure 20. Global Type 2 Diabetes Medication Market Size Market Share by Application in 2019
Figure 21. Global Type 2 Diabetes Medication Market Size Market Share by Regions 2015-2020
Figure 22. Americas Type 2 Diabetes Medication Market Size 2015-2020 ($ Millions)
Figure 23. APAC Type 2 Diabetes Medication Market Size 2015-2020 ($ Millions)
Figure 24. Europe Type 2 Diabetes Medication Market Size 2015-2020 ($ Millions)
Figure 25. Middle East & Africa Type 2 Diabetes Medication Market Size 2015-2020 ($ Millions)
Figure 26. Americas Type 2 Diabetes Medication Market Size Market Share by Countries in 2019
Figure 27. Americas Type 2 Diabetes Medication Market Size Market Share by Type in 2019
Figure 28. Americas Type 2 Diabetes Medication Market Size Market Share by Application in 2019
Figure 29. United States Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 30. Canada Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 31. Mexico Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 32. APAC Type 2 Diabetes Medication Market Size Market Share by Regions in 2019
Figure 33. APAC Type 2 Diabetes Medication Market Size Market Share by Type in 2019
Figure 34. APAC Type 2 Diabetes Medication Market Size Market Share by Application in 2019
Figure 35. China Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 36. Japan Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 37. Korea Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 38. Southeast Asia Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 39. India Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 40. Australia Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 41. Europe Type 2 Diabetes Medication Market Size Market Share by Countries in 2019
Figure 42. Europe Type 2 Diabetes Medication Market Size Market Share by Type in 2019
Figure 43. Europe Type 2 Diabetes Medication Market Size Market Share by Application in 2019
Figure 44. Germany Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 45. France Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 46. UK Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 47. Italy Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 48. Russia Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 49. Spain Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 50. Middle East & Africa Type 2 Diabetes Medication Market Size Market Share by Countries in 2019
Figure 51. Middle East & Africa Type 2 Diabetes Medication Market Size Market Share by Type in 2019
Figure 52. Middle East & Africa Type 2 Diabetes Medication Market Size Market Share by Application in 2019
Figure 53. Egypt Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 54. South Africa Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 55. Israel Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 56. Turkey Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 57. GCC Countries Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 58. Global Type 2 Diabetes Medication arket Size Forecast (2021-2025) ($ Millions)
Figure 59. Americas Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 60. APAC Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 61. Europe Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 62. Middle East & Africa Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 63. United States Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 64. Canada Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 65. Mexico Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 66. Brazil Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 67. China Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 68. Japan Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 69. Korea Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 70. Southeast Asia Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 71. India Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 72. Australia Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 73. Germany Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 74. France Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 75. UK Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 76. Italy Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 77. Russia Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 78. Spain Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 79. Egypt Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 80. South Africa Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 81. Israel Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 82. Turkey Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 83. GCC Countries Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Table 1. Research Methodology
Table 2. Data Source
Table 3. Type 2 Diabetes Medication Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Biguanides
Table 5. Major Players of Sulphonylureas
Table 6. Major Players of Thiazolidinediones
Table 7. Major Players of Alpha-glucosidase Inhibitors
Table 8. Major Players of DPP-4 Inhibitors
Table 9. Major Players of GLP-1 Receptor Agonists
Table 10. Major Players of SGLT-2 Inhibitors
Table 11. Major Players of Insulins
Table 12. Type 2 Diabetes Medication Market Size by Type (2014-2019) ($ Millions)
Table 13. Global Type 2 Diabetes Medication Market Size Market Share by Type (2015-2020)
Table 14. Global Type 2 Diabetes Medication Market Size by Application (2015-2020) ($ Millions)
Table 15. Global Type 2 Diabetes Medication Market Size Market Share by Application (2015-2020)
Table 16. Global Type 2 Diabetes Medication Revenue by Players (2018-2020) ($ Millions)
Table 17. Global Type 2 Diabetes Medication Revenue Market Share by Players (2018-2020)
Table 18. Global Type 2 Diabetes Medication Key Players Head office and Products Offered
Table 19. Type 2 Diabetes Medication Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global Type 2 Diabetes Medication Market Size by Regions 2015-2020 ($ Millions)
Table 23. Global Type 2 Diabetes Medication Market Size Market Share by Regions 2015-2020
Table 24. Americas Type 2 Diabetes Medication Market Size by Countries (2015-2020) ($ Millions)
Table 25. Americas Type 2 Diabetes Medication Market Size Market Share by Countries (2015-2020)
Table 26. Americas Type 2 Diabetes Medication Market Size by Type (2015-2020) ($ Millions)
Table 27. Americas Type 2 Diabetes Medication Market Size Market Share by Type (2015-2020)
Table 28. Americas Type 2 Diabetes Medication Market Size by Application (2015-2020) ($ Millions)
Table 29. Americas Type 2 Diabetes Medication Market Size Market Share by Application (2015-2020)
Table 30. APAC Type 2 Diabetes Medication Market Size by Regions (2015-2020) ($ Millions)
Table 31. APAC Type 2 Diabetes Medication Market Size Market Share by Regions (2015-2020)
Table 32. APAC Type 2 Diabetes Medication Market Size by Type (2015-2020) ($ Millions)
Table 33. APAC Type 2 Diabetes Medication Market Size Market Share by Type (2015-2020)
Table 34. APAC Type 2 Diabetes Medication Market Size by Application (2015-2020) ($ Millions)
Table 35. APAC Type 2 Diabetes Medication Market Size Market Share by Application (2015-2020)
Table 36. Europe Type 2 Diabetes Medication Market Size by Countries (2015-2020) ($ Millions)
Table 37. Europe Type 2 Diabetes Medication Market Size Market Share by Countries (2015-2020)
Table 38. Europe Type 2 Diabetes Medication Market Size by Type (2015-2020) ($ Millions)
Table 39. Europe Type 2 Diabetes Medication Market Size Market Share by Type (2015-2020)
Table 40. Europe Type 2 Diabetes Medication Market Size by Application (2015-2020) ($ Millions)
Table 41. Europe Type 2 Diabetes Medication Market Size Market Share by Application (2015-2020)
Table 42. Middle East & Africa Type 2 Diabetes Medication Market Size by Countries (2015-2020) ($ Millions)
Table 43. Middle East & Africa Type 2 Diabetes Medication Market Size Market Share by Countries (2015-2020)
Table 44. Middle East & Africa Type 2 Diabetes Medication Market Size by Type (2015-2020) ($ Millions)
Table 45. Middle East & Africa Type 2 Diabetes Medication Market Size Market Share by Type (2015-2020)
Table 46. Middle East & Africa Type 2 Diabetes Medication Market Size by Application (2015-2020) ($ Millions)
Table 47. Middle East & Africa Type 2 Diabetes Medication Market Size Market Share by Application (2015-2020)
Table 48. Key and Potential Regions of Type 2 Diabetes Medication
Table 49. Key Application and Potential Industries of Type 2 Diabetes Medication
Table 50. Key Challenges of Type 2 Diabetes Medication
Table 51. Key Trends of Type 2 Diabetes Medication
Table 52. Global Type 2 Diabetes Medication Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 53. Global Type 2 Diabetes Medication Market Size Market Share Forecast by Regions
Table 54. Global Type 2 Diabetes Medication Market Size Forecast by Type (2021-2025) ($ Millions)
Table 55. Global Type 2 Diabetes Medication Market Size Market Share Forecast by Type (2021-2025)
Table 56. Global Type 2 Diabetes Medication Market Size Forecast by Application (2021-2025) ($ Millions)
Table 57. Global Type 2 Diabetes Medication Market Size Market Share Forecast by Application (2021-2025)
Table 58. AstraZeneca Details, Company Total Revenue (in $ million), Head Office, Type 2 Diabetes Medication Major Market Areas and Its Competitors
Table 59. AstraZeneca Type 2 Diabetes Medication Product Offered
Table 60. AstraZeneca Type 2 Diabetes Medication Revenue and Gross Margin (2018-2020E)
Table 61. AstraZeneca Main Business
Table 62. AstraZeneca Latest Developments
Table 63. Pfizer Details, Company Total Revenue (in $ million), Head Office, Type 2 Diabetes Medication Major Market Areas and Its Competitors
Table 64. Pfizer Type 2 Diabetes Medication Product Offered
Table 65. Pfizer Main Business
Table 66. Pfizer Type 2 Diabetes Medication Revenue and Gross Margin (2018-2020E)
Table 67. Pfizer Latest Developments
Table 68. Novartis Details, Company Total Revenue (in $ million), Head Office, Type 2 Diabetes Medication Major Market Areas and Its Competitors
Table 69. Novartis Type 2 Diabetes Medication Product Offered
Table 70. Novartis Main Business
Table 71. Novartis Type 2 Diabetes Medication Revenue and Gross Margin (2018-2020E)
Table 72. Novartis Latest Developments
Table 73. Johnson & Johnson Details, Company Total Revenue (in $ million), Head Office, Type 2 Diabetes Medication Major Market Areas and Its Competitors
Table 74. Johnson & Johnson Type 2 Diabetes Medication Product Offered
Table 75. Johnson & Johnson Main Business
Table 76. Johnson & Johnson Type 2 Diabetes Medication Revenue and Gross Margin (2018-2020E)
Table 77. Johnson & Johnson Latest Developments
Table 78. Boehringer Ingelheim Details, Company Total Revenue (in $ million), Head Office, Type 2 Diabetes Medication Major Market Areas and Its Competitors
Table 79. Boehringer Ingelheim Type 2 Diabetes Medication Product Offered
Table 80. Boehringer Ingelheim Main Business
Table 81. Boehringer Ingelheim Type 2 Diabetes Medication Revenue and Gross Margin (2018-2020E)
Table 82. Boehringer Ingelheim Latest Developments
Table 83. Novo Nordisk Details, Company Total Revenue (in $ million), Head Office, Type 2 Diabetes Medication Major Market Areas and Its Competitors
Table 84. Novo Nordisk Type 2 Diabetes Medication Product Offered
Table 85. Novo Nordisk Main Business
Table 86. Novo Nordisk Type 2 Diabetes Medication Revenue and Gross Margin (2018-2020E)
Table 87. Novo Nordisk Latest Developments
Table 88. Merck Details, Company Total Revenue (in $ million), Head Office, Type 2 Diabetes Medication Major Market Areas and Its Competitors
Table 89. Merck Type 2 Diabetes Medication Product Offered
Table 90. Merck Main Business
Table 91. Merck Type 2 Diabetes Medication Revenue and Gross Margin (2018-2020E)
Table 92. Merck Latest Developments
Table 93. Bristol-Myers Squibb Details, Company Total Revenue (in $ million), Head Office, Type 2 Diabetes Medication Major Market Areas and Its Competitors
Table 94. Bristol-Myers Squibb Type 2 Diabetes Medication Product Offered
Table 95. Bristol-Myers Squibb Main Business
Table 96. Bristol-Myers Squibb Type 2 Diabetes Medication Revenue and Gross Margin (2018-2020E)
Table 97. Bristol-Myers Squibb Latest Developments
Table 98. Sanofi Details, Company Total Revenue (in $ million), Head Office, Type 2 Diabetes Medication Major Market Areas and Its Competitors
Table 99. Sanofi Type 2 Diabetes Medication Product Offered
Table 100. Sanofi Main Business
Table 101. Sanofi Type 2 Diabetes Medication Revenue and Gross Margin (2018-2020E)
Table 102. Sanofi Latest Developments
Table 103. Eli Lilly Details, Company Total Revenue (in $ million), Head Office, Type 2 Diabetes Medication Major Market Areas and Its Competitors
Table 104. Eli Lilly Type 2 Diabetes Medication Product Offered
Table 105. Eli Lilly Main Business
Table 106. Eli Lilly Type 2 Diabetes Medication Revenue and Gross Margin (2018-2020E)
Table 107. Eli Lilly Latest Developments
Table 108. Takeda Details, Company Total Revenue (in $ million), Head Office, Type 2 Diabetes Medication Major Market Areas and Its Competitors
Table 109. Sun pharma Details, Company Total Revenue (in $ million), Head Office, Type 2 Diabetes Medication Major Market Areas and Its Competitors
Table 110. Astellas Pharma Details, Company Total Revenue (in $ million), Head Office, Type 2 Diabetes Medication Major Market Areas and Its Competitors
Table 111. Glenmark Details, Company Total Revenue (in $ million), Head Office, Type 2 Diabetes Medication Major Market Areas and Its Competitors
Table 112. Biocon Details, Company Total Revenue (in $ million), Head Office, Type 2 Diabetes Medication Major Market Areas and Its Competitors
Table 113. Bayer AG Details, Company Total Revenue (in $ million), Head Office, Type 2 Diabetes Medication Major Market Areas and Its Competitors
Table 114. Daiichi Sankyo Details, Company Total Revenue (in $ million), Head Office, Type 2 Diabetes Medication Major Market Areas and Its Competitors
List of Figures
Figure 1. Type 2 Diabetes Medication Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Type 2 Diabetes Medication Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Type 2 Diabetes Medication Market Size Market Share by Type (2015-2020)
Figure 5. Global Biguanides Market Size Growth Rate
Figure 6. Global Sulphonylureas Market Size Growth Rate
Figure 7. Global Thiazolidinediones Market Size Growth Rate
Figure 8. Global Alpha-glucosidase Inhibitors Market Size Growth Rate
Figure 9. Global DPP-4 Inhibitors Market Size Growth Rate
Figure 10. Global GLP-1 Receptor Agonists Market Size Growth Rate
Figure 11. Global SGLT-2 Inhibitors Market Size Growth Rate
Figure 12. Global Insulins Market Size Growth Rate
Figure 13. Type 2 Diabetes Medication in Hospital Pharmacies
Figure 14. Global Type 2 Diabetes Medication Market: Hospital Pharmacies (2015-2020) ($ Millions)
Figure 15. Type 2 Diabetes Medication in Retail Pharmacies
Figure 16. Global Type 2 Diabetes Medication Market: Retail Pharmacies (2015-2020) ($ Millions)
Figure 17. Type 2 Diabetes Medication in Online Pharmacies
Figure 18. Global Type 2 Diabetes Medication Market: Online Pharmacies (2015-2020) ($ Millions)
Figure 19. Global Online Pharmacies YoY Growth ($ Millions)
Figure 20. Global Type 2 Diabetes Medication Market Size Market Share by Application in 2019
Figure 21. Global Type 2 Diabetes Medication Market Size Market Share by Regions 2015-2020
Figure 22. Americas Type 2 Diabetes Medication Market Size 2015-2020 ($ Millions)
Figure 23. APAC Type 2 Diabetes Medication Market Size 2015-2020 ($ Millions)
Figure 24. Europe Type 2 Diabetes Medication Market Size 2015-2020 ($ Millions)
Figure 25. Middle East & Africa Type 2 Diabetes Medication Market Size 2015-2020 ($ Millions)
Figure 26. Americas Type 2 Diabetes Medication Market Size Market Share by Countries in 2019
Figure 27. Americas Type 2 Diabetes Medication Market Size Market Share by Type in 2019
Figure 28. Americas Type 2 Diabetes Medication Market Size Market Share by Application in 2019
Figure 29. United States Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 30. Canada Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 31. Mexico Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 32. APAC Type 2 Diabetes Medication Market Size Market Share by Regions in 2019
Figure 33. APAC Type 2 Diabetes Medication Market Size Market Share by Type in 2019
Figure 34. APAC Type 2 Diabetes Medication Market Size Market Share by Application in 2019
Figure 35. China Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 36. Japan Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 37. Korea Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 38. Southeast Asia Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 39. India Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 40. Australia Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 41. Europe Type 2 Diabetes Medication Market Size Market Share by Countries in 2019
Figure 42. Europe Type 2 Diabetes Medication Market Size Market Share by Type in 2019
Figure 43. Europe Type 2 Diabetes Medication Market Size Market Share by Application in 2019
Figure 44. Germany Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 45. France Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 46. UK Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 47. Italy Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 48. Russia Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 49. Spain Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 50. Middle East & Africa Type 2 Diabetes Medication Market Size Market Share by Countries in 2019
Figure 51. Middle East & Africa Type 2 Diabetes Medication Market Size Market Share by Type in 2019
Figure 52. Middle East & Africa Type 2 Diabetes Medication Market Size Market Share by Application in 2019
Figure 53. Egypt Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 54. South Africa Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 55. Israel Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 56. Turkey Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 57. GCC Countries Type 2 Diabetes Medication Market Size Growth 2015-2020 ($ Millions)
Figure 58. Global Type 2 Diabetes Medication arket Size Forecast (2021-2025) ($ Millions)
Figure 59. Americas Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 60. APAC Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 61. Europe Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 62. Middle East & Africa Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 63. United States Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 64. Canada Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 65. Mexico Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 66. Brazil Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 67. China Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 68. Japan Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 69. Korea Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 70. Southeast Asia Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 71. India Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 72. Australia Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 73. Germany Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 74. France Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 75. UK Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 76. Italy Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 77. Russia Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 78. Spain Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 79. Egypt Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 80. South Africa Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 81. Israel Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 82. Turkey Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
Figure 83. GCC Countries Type 2 Diabetes Medication Market Size 2021-2025 ($ Millions)
